GSH treatment led to a highly significant improvement in myeloid maturation in a dose-dependent manner.
← all excerpts
Reticular dysgenesis-associated AK2 protects hematopoietic stem and progenitor cell development from oxidative stress.
1
—
—
GSH treatment led to a highly significant improvement in myeloid maturation in a dose-dependent manner.